Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye

PURPOSE: Two new drugs with mucin-inducing and secretion-promotive effects, rebamipide and diquafosol, were recently approved as topical dry-eye treatments. We report two cases in which the long-term use of mucin-inducing eye drops improved chronic ocular graft-versus-host disease (cGVHD)–related dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamane, Mio, Ogawa, Yoko, Fukui, Masaki, Kamoi, Mizuka, Saijo-Ban, Yumiko, Yaguchi, Saori, Mukai, Shin, Kawakita, Tetsuya, Simmura, Shigeto, Tsubota, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Clinical Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376271/
https://www.ncbi.nlm.nih.gov/pubmed/25785527
http://dx.doi.org/10.1097/OPX.0000000000000523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376271/
https://www.ncbi.nlm.nih.gov/pubmed/25785527
http://dx.doi.org/10.1097/OPX.0000000000000523

Ejemplares similares